CSI Market
Sign In | Register

Ultragenyx Pharmaceutical Inc (RARE) Annual Balance Sheets

Annual · GAAP · USD millions
Access RARE quarterly Balance Sheets →
A period-by-period view of the balance sheet from Ultragenyx Pharmaceutical Inc to Dec 31 2021 helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent421.00
Available-for-sale Securities, Debt Securities, Current MA259.00
Cash & Short-term Investments680.00
Accounts receivable158.00
Inventories52.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current61.00
Total Current Assets951.00
Equipment/Property/Plant Net244.00
Goodwill net44.00
Intangible Assets176.00
Long-term investments57.00
Other Assets, Noncurrent117.00
Operating Lease Right Of Use Asset0.00
Total Assets1,532.00
Liabilities
Accounts Payable, Current AC31.00
Accrued Liabilities, Current AC265.00
Other Liabilities, Current7.00
Total Current Liabilities384.00
Total Long-term Debt0.00
Other liabilities, Noncurrent1,221.00
Operating Lease Liability Current12.00
Liabilities For Sales Of Future Royalties Current69.00
Operating Lease Liability Noncurrent24.00
Liability Related To Sale Of Future Royalties1,147.00
Total Liabilities1,605.00
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value8.00
Additional Paid In Capital Common Stock4,451.00
Retained Earnings / Accumulated Deficit-4,532.00
Other Equity-14.00
Common Stockholder's Equity-87.00
Non-controlling interests & other7.00
Total Stockholder's Equity-80.00
Liabilities & Stockholder's Equity1,532.00
4 historic quarters locked

Sign in to unlock the full Ultragenyx Pharmaceutical Inc balance sheet history.

Sign In Create Free Account

About Ultragenyx Pharmaceutical Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 18, 2026
  • Source: rare-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-057329

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License